Precise.
Reliable.
Accessible.
Neuroimaging
Kernel is Transforming Neuromedicine
Kernel's category-defining neuroimaging platform can be used to accelerate treatment development, improve patient outcomes, and reduce healthcare costs.
Treatment Response
Prediction
Leverage brain-based biomarkers to identify patients who are most likely to have positive treatment responses. This capability will empower clinicians with more data for decision making and lead to better outcomes for patients.
Translational
Research
Use measures from Kernel Flow to acutely identify signatures that demonstrate new treatments are functionally engaging the brain.
Clinical Trial
Optimization
Increase the efficiency of clinical trials with better tools to stratify patients, quantify endpoints, provide quick answers, and precisely measure drug effects.
Early
Identification
Measure the brain quickly and easily using Kernel Flow. Regular and robust monitoring of brain function has never before been possible but will become a standard part of every checkup.
Our Platform Is
Data Rich
Kernel Flow is a premium multimodal neuroimaging headset, fusing high-resolution hemodynamics and EEG to provide a comprehensive picture of cortical brain activity.
Our Platform Is
Easy-to-Use
Flow is portable and takes less than 3 minutes to set up. Our user-friendly software and analysis pipelines provide immediate access to research-grade neuroimaging results.
Our Platform Is
Proven
Validated through multiple peer-reviewed publications, Kernel Flow builds on decades of functional neuroimaging advances.
We Build Precision
Biomarkers
Kernel's AI and ML tools produce actionable biomarkers that take advantage of the volume of information-rich data that can quickly be gathered with Flow.
Ketamine
Complete
Kernel Flow measures a biomarker for the acute effect of subanesthetic ketamine on the brain.
Read Publication At
Alcohol
Complete
Kernel Flow measures a biomarker that can distinguish cognitive impairment levels due to alcohol intoxication.
Read Publication At
Depression
Active
Enrolling by invitation in clinics across the West Coast for a biomarker study measuring various depression treatments.
Learn More At
Cognitive
Decline
Active
Recruiting healthy controls and MCI patients for a biomarker study measuring aging in adults over the age of 55.
Learn More At
Partner With Us
Together, we can revolutionize precision neuromedicine.
As the leader in non-invasive neuroimaging, Kernel believes in data-driven development and scalable technology. Our brain-based biomarkers, action-focused solutions, and reliable data can empower and accelerate your goals. Transform the future of neuromedicine today by partnering with us.